Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/α2-macroglobulin receptor

Kim Orth, Edwin L. Madison, Mary Jane Gething, Joseph F. Sambrook, Joachim Herz

Research output: Contribution to journalArticle

209 Citations (Scopus)

Abstract

Tissue-type plasminogen activator and urokinase are serine proteases secreted by many cell types that participate in biological processes, such as tissue restructuring, cell migration, and tumor metastasis. Clinically, these proteases are used to dissolve coronary fibrin clots that are the proximal causes of acute myocardial infarction. In vivo, the activity of these enzymes is controlled by plasminogen-activator inhibitors, members of the serpin family of protease inhibitors. This study shows that tissue-type plasminogen activator-inhibitor complexes bind in solution to low density lipoprotein receptor-related protein (LRP), a large heterodimeric ubiquitous membrane receptor. In cultured cells, endocytosis and degradation of these complexes is reduced by polyclonal antibodies directed against LRP and inhibited by a Mr 39,000 protein that binds to LRP and inhibits its interaction with previously known ligands, including apolipoprotein E and α2-macroglobulin. We propose a role for LRP in the clearance of plasminogen activator-inhibitor complexes that is analogous to its function in the endocytosis of α2-macroglobulin-protease complexes.

Original languageEnglish (US)
Pages (from-to)7422-7426
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume89
Issue number16
StatePublished - 1992

Fingerprint

Low Density Lipoprotein Receptor-Related Protein-2
Serpins
Plasminogen Inactivators
Macroglobulins
Plasminogen Activator Inhibitor 1
Tissue Plasminogen Activator
Lipoprotein Receptors
Endocytosis
Proteins
Peptide Hydrolases
LDL-Receptor Related Proteins
Apolipoprotein E2
Biological Phenomena
LDL Receptors
Urokinase-Type Plasminogen Activator
Serine Proteases
Protease Inhibitors
Fibrin
Cell Movement
Cultured Cells

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

@article{6b38401d96a5450397268b513c8d5f27,
title = "Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/α2-macroglobulin receptor",
abstract = "Tissue-type plasminogen activator and urokinase are serine proteases secreted by many cell types that participate in biological processes, such as tissue restructuring, cell migration, and tumor metastasis. Clinically, these proteases are used to dissolve coronary fibrin clots that are the proximal causes of acute myocardial infarction. In vivo, the activity of these enzymes is controlled by plasminogen-activator inhibitors, members of the serpin family of protease inhibitors. This study shows that tissue-type plasminogen activator-inhibitor complexes bind in solution to low density lipoprotein receptor-related protein (LRP), a large heterodimeric ubiquitous membrane receptor. In cultured cells, endocytosis and degradation of these complexes is reduced by polyclonal antibodies directed against LRP and inhibited by a Mr 39,000 protein that binds to LRP and inhibits its interaction with previously known ligands, including apolipoprotein E and α2-macroglobulin. We propose a role for LRP in the clearance of plasminogen activator-inhibitor complexes that is analogous to its function in the endocytosis of α2-macroglobulin-protease complexes.",
author = "Kim Orth and Madison, {Edwin L.} and Gething, {Mary Jane} and Sambrook, {Joseph F.} and Joachim Herz",
year = "1992",
language = "English (US)",
volume = "89",
pages = "7422--7426",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "16",

}

TY - JOUR

T1 - Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/α2-macroglobulin receptor

AU - Orth, Kim

AU - Madison, Edwin L.

AU - Gething, Mary Jane

AU - Sambrook, Joseph F.

AU - Herz, Joachim

PY - 1992

Y1 - 1992

N2 - Tissue-type plasminogen activator and urokinase are serine proteases secreted by many cell types that participate in biological processes, such as tissue restructuring, cell migration, and tumor metastasis. Clinically, these proteases are used to dissolve coronary fibrin clots that are the proximal causes of acute myocardial infarction. In vivo, the activity of these enzymes is controlled by plasminogen-activator inhibitors, members of the serpin family of protease inhibitors. This study shows that tissue-type plasminogen activator-inhibitor complexes bind in solution to low density lipoprotein receptor-related protein (LRP), a large heterodimeric ubiquitous membrane receptor. In cultured cells, endocytosis and degradation of these complexes is reduced by polyclonal antibodies directed against LRP and inhibited by a Mr 39,000 protein that binds to LRP and inhibits its interaction with previously known ligands, including apolipoprotein E and α2-macroglobulin. We propose a role for LRP in the clearance of plasminogen activator-inhibitor complexes that is analogous to its function in the endocytosis of α2-macroglobulin-protease complexes.

AB - Tissue-type plasminogen activator and urokinase are serine proteases secreted by many cell types that participate in biological processes, such as tissue restructuring, cell migration, and tumor metastasis. Clinically, these proteases are used to dissolve coronary fibrin clots that are the proximal causes of acute myocardial infarction. In vivo, the activity of these enzymes is controlled by plasminogen-activator inhibitors, members of the serpin family of protease inhibitors. This study shows that tissue-type plasminogen activator-inhibitor complexes bind in solution to low density lipoprotein receptor-related protein (LRP), a large heterodimeric ubiquitous membrane receptor. In cultured cells, endocytosis and degradation of these complexes is reduced by polyclonal antibodies directed against LRP and inhibited by a Mr 39,000 protein that binds to LRP and inhibits its interaction with previously known ligands, including apolipoprotein E and α2-macroglobulin. We propose a role for LRP in the clearance of plasminogen activator-inhibitor complexes that is analogous to its function in the endocytosis of α2-macroglobulin-protease complexes.

UR - http://www.scopus.com/inward/record.url?scp=0026668601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026668601&partnerID=8YFLogxK

M3 - Article

C2 - 1502153

AN - SCOPUS:0026668601

VL - 89

SP - 7422

EP - 7426

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 16

ER -